Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Blumberg

Showing results (111-120 of 183) with videos related to

Pageof 19
Sort By:
Chembiochem : a European Journal of Chemical Biology|April 30, 2014
Charge density influences C1 domain ligand affinity and membrane interactionsJessica S Kelsey, Tamas Geczy, Nancy E Lewin, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
The SAR analysis of TRPV1 agonists with the α-methylated B-regionYongsung Cho, Myeong Seop Kim, Ho Shin Kim, et al.
Organic Letters|December 31, 2008
Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol estersGary E Keck, Yam B Poudel, Dennie S Welch, et al.
Journal of Medicinal Chemistry|April 22, 2009
Conformationally constrained analogues of diacylglycerol (DAG). 31. Modulation of the biological properties of diacylgycerol lactones (DAG-lactones) containing rigid-rod acyl groups separated from the core lactone by spacer units of different lengthsMaria J Comin, Gabriella Czifra, Noemi Kedei, et al.
Journal of Medicinal Chemistry|March 19, 2004
Antineoplastic agents. 499. Synthesis of hystatin 2 and related 1H-benzo[de][1,6]-naphthyridinium salts from aaptamineGeorge R Pettit, Holger Hoffmann, Delbert L Herald, et al.
Oncogene|May 24, 2011
RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanomaDazhi Yang, Juan Tao, Luowei Li, et al.
Journal of Cellular and Molecular Medicine|October 7, 2014
Protein kinase Cδ promotes proliferation and induces malignant transformation in skeletal muscleGabriella Czifra, Attila Szöllősi, Zsuzsanna Nagy, et al.
Bioorganic & Medicinal Chemistry|January 16, 2004
N-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure-activity relationships for the "C-Region"Jeewoo Lee, Sang-Uk Kang, Ju-Ok Lim, et al.
Molecular Pharmacology|January 19, 2006
Kinetics of penetration influence the apparent potency of vanilloids on TRPV1Jozsef Lazar, Derek C Braun, Attila Tóth, et al.
Bioorganic & Medicinal Chemistry|April 11, 2017
Exploring the influence of indololactone structure on selectivity for binding to the C1 domains of PKCα, PKCε, and RasGRPEleonora Elhalem, Lucía Gandolfi Donadío, Xiaoling Zhou, et al.
Pageof 19

Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Chembiochem : a European Journal of Chemical Biology|April 30, 2014
Charge density influences C1 domain ligand affinity and membrane interactionsJessica S Kelsey, Tamas Geczy, Nancy E Lewin, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
The SAR analysis of TRPV1 agonists with the α-methylated B-regionYongsung Cho, Myeong Seop Kim, Ho Shin Kim, et al.
Organic Letters|December 31, 2008
Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol estersGary E Keck, Yam B Poudel, Dennie S Welch, et al.
Journal of Medicinal Chemistry|April 22, 2009
Conformationally constrained analogues of diacylglycerol (DAG). 31. Modulation of the biological properties of diacylgycerol lactones (DAG-lactones) containing rigid-rod acyl groups separated from the core lactone by spacer units of different lengthsMaria J Comin, Gabriella Czifra, Noemi Kedei, et al.
Journal of Medicinal Chemistry|March 19, 2004
Antineoplastic agents. 499. Synthesis of hystatin 2 and related 1H-benzo[de][1,6]-naphthyridinium salts from aaptamineGeorge R Pettit, Holger Hoffmann, Delbert L Herald, et al.
Oncogene|May 24, 2011
RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanomaDazhi Yang, Juan Tao, Luowei Li, et al.
Journal of Cellular and Molecular Medicine|October 7, 2014
Protein kinase Cδ promotes proliferation and induces malignant transformation in skeletal muscleGabriella Czifra, Attila Szöllősi, Zsuzsanna Nagy, et al.
Bioorganic & Medicinal Chemistry|January 16, 2004
N-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure-activity relationships for the "C-Region"Jeewoo Lee, Sang-Uk Kang, Ju-Ok Lim, et al.
Molecular Pharmacology|January 19, 2006
Kinetics of penetration influence the apparent potency of vanilloids on TRPV1Jozsef Lazar, Derek C Braun, Attila Tóth, et al.
Bioorganic & Medicinal Chemistry|April 11, 2017
Exploring the influence of indololactone structure on selectivity for binding to the C1 domains of PKCα, PKCε, and RasGRPEleonora Elhalem, Lucía Gandolfi Donadío, Xiaoling Zhou, et al.
Pageof 19